Welcome to Avipep

Avipep Pty Ltd (Avipep) is a biotechnology company commercializing Avibody™ products, new protein biopharmaceuticals and in vivo diagnostic products.

Avibody™ products comprise the antigen-binding V-domains of antibodies and have improved properties for the detection and treatment of specific cancers and other human diseases.

The Avibody™ Platform

Avipep can produce, customize and stabilize Avibody™ products for therapy and in vivo clinical imaging. Avipep can also load Avibody™ products with cytotoxic drug payloads or diagnostic tracers.

Avipep focuses on treatments for cancers of the breast, colon and prostate.

Latest News:

Avipep was awarded a Victoria's Science Agenda (VSA) Investment Fund grant to form the Victorian Cancer Biologics (VCB) consortium and develop "High value clinical products for oncology diagnosis and therapy.
> Click here for more.




Copyright © 2007 Avipep Pty Ltd. All rights reserved. Please read the disclaimer for further information.

Interface Design by Think Soda